Rini Life Science is an API manufacturer based in India. It holds one active US drug master file. Customs aggregates show $1.1M of exports covering 89 molecules to 20 destinations in 2025.
| Molecule | Regulators | Docs |
|---|---|---|
| Chlorzoxazone | US FDA | 1 |
Also appears on these molecule pages
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $88K | 3 |
| 2025 | Not reported | $1.1M | 20 |
| 2024 | Not reported | $1.1M | 14 |
| 2023 | Not reported | $1.2M | 13 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Ask Fred what the record holds on Rini Life Science, including filings and inspection history.
Chat with Fred, your AI analystRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.